Market Cap 1.00B
Revenue (ttm) 49.80M
Net Income (ttm) -50.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.08%
Debt to Equity Ratio 0.29
Volume 2,335,800
Avg Vol 3,635,614
Day's Range N/A - N/A
Shares Out 444.96M
Stochastic %K 9%
Beta 1.08
Analysts Sell
Price Target $3.86

Company Profile

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospit...

Industry: Biotechnology
Sector: Healthcare
Phone: 281 863 3000
Fax: 281 863 8088
Address:
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, United States
sabill
sabill Sep. 2 at 8:40 PM
$LXRX The occasional massive 4pm stock dumps sure screw up the average volume numbers.
0 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
0 · Reply
gucag006
gucag006 Sep. 2 at 6:30 PM
$LXRX Add some more this morning @2.21.
0 · Reply
CatchTheCleanUpSet
CatchTheCleanUpSet Sep. 2 at 5:56 PM
$LXRX Steno1 DKA results are now in hand.
1 · Reply
Hit1000X
Hit1000X Sep. 2 at 5:03 PM
0 · Reply
Dooright
Dooright Sep. 2 at 3:04 PM
$LXRX Fecking gap up this morning finally filled! 😖🙄 Doc C. 🤓
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:37 PM
$LXRX Tutes and MM's keep fucking with Debbane's 10 mil purchase in February. They keep poking the tiger. Just waiting with popcorn.
1 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:35 PM
$LXRX 3 dollar supports in short order.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:17 PM
$LXRX Oh look, it's climbing, what a surprise.
0 · Reply
Planetpaprika
Planetpaprika Sep. 2 at 11:41 AM
$LXRX Citi 2026 Biopharma Back to School Conference September 9, 2026, 11:20–11:55 AM (Eastern Time) 2026 Cantor Global Healthcare Conference September 10, 2026, 3:20–3:50 PM (Eastern Time) H.C. Wainwright 28th Annual Global Investment Conference September 14, 2026, 9:00–9:30 AM (Eastern Time)
0 · Reply
Latest News on LXRX
Lexicon reports Q2 EPS (7c), consensus (5c)

2026-08-06T13:06:54.000Z - 27 days ago

Lexicon reports Q2 EPS (7c), consensus (5c)


Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 27 days ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2026


Lexicon Pharmaceuticals Earnings release: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 27 days ago

Lexicon Pharmaceuticals Earnings release: Q2 2026


Lexicon Pharmaceuticals Slides: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 27 days ago

Lexicon Pharmaceuticals Slides: Q2 2026


Lexicon Pharmaceuticals Quarterly report: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 27 days ago

Lexicon Pharmaceuticals Quarterly report: Q2 2026


Lexicon completes enrollment in SONATA-HCM study

2026-07-27T13:15:42.000Z - 5 weeks ago

Lexicon completes enrollment in SONATA-HCM study


Lexicon Pharmaceuticals Slides: Investor presentation

May 26, 2026, 7:00 AM EDT - 3 months ago

Lexicon Pharmaceuticals Slides: Investor presentation


Lexicon price target raised to $3.10 from $2.30 at Citi

2026-05-11T11:01:50.000Z - 3 months ago

Lexicon price target raised to $3.10 from $2.30 at Citi


Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2026


Lexicon Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Lexicon Pharmaceuticals Earnings release: Q1 2026


Lexicon Pharmaceuticals Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Lexicon Pharmaceuticals Slides: Q1 2026


Lexicon Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Lexicon Pharmaceuticals Quarterly report: Q1 2026


Lexicon, Novo Nordisk announce initiation of LX9851 study

2026-03-23T11:46:37.000Z - 5 months ago

Lexicon, Novo Nordisk announce initiation of LX9851 study

NVO


Lexicon Pharmaceuticals Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Lexicon Pharmaceuticals Proxy statement: Proxy Filing


Lexicon Pharmaceuticals Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Lexicon Pharmaceuticals Proxy statement: Proxy Filing


Lexicon price target raised to $2.30 from $2.10 at Citi

2026-03-10T10:53:36.000Z - 5 months ago

Lexicon price target raised to $2.30 from $2.10 at Citi


Lexicon price target raised to $6 from $4 at H.C. Wainwright

2026-03-05T16:06:30.000Z - 6 months ago

Lexicon price target raised to $6 from $4 at H.C. Wainwright


Lexicon Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q4 2025


Lexicon Pharmaceuticals Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Lexicon Pharmaceuticals Annual report: Q4 2025


Lexicon Pharmaceuticals Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Lexicon Pharmaceuticals Earnings release: Q4 2025


Lexicon Pharmaceuticals Slides: Q4 2025

Mar 5, 2026, 8:30 AM EST - 6 months ago

Lexicon Pharmaceuticals Slides: Q4 2025


Lexicon reports Q4 EPS (4c), consensus (7c)

2026-03-05T12:08:49.000Z - 6 months ago

Lexicon reports Q4 EPS (4c), consensus (7c)


Lexicon Pharmaceuticals Proxy statement: Proxy Filing

Feb 17, 2026, 7:00 AM EST - 6 months ago

Lexicon Pharmaceuticals Proxy statement: Proxy Filing


Lexicon announces common stock offering, no amount given

2026-01-29T21:36:16.000Z - 7 months ago

Lexicon announces common stock offering, no amount given


Lexicon Announces Proposed Public Offering of Common Stock

Jan 29, 2026, 4:31 PM EST - 7 months ago

Lexicon Announces Proposed Public Offering of Common Stock


Lexicon price target raised to $2.10 from $1.90 at Citi

2026-01-14T10:45:10.000Z - 7 months ago

Lexicon price target raised to $2.10 from $1.90 at Citi


Lexicon Pharmaceuticals Slides: Corporate presentation

Nov 14, 2025, 7:00 AM EST - 9 months ago

Lexicon Pharmaceuticals Slides: Corporate presentation


Lexicon Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q3 2025


Lexicon Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Lexicon Pharmaceuticals Quarterly report: Q3 2025


Lexicon Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Lexicon Pharmaceuticals Earnings release: Q3 2025


Lexicon Pharmaceuticals Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Lexicon Pharmaceuticals Slides: Q3 2025


Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2025


Lexicon Pharmaceuticals Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Lexicon Pharmaceuticals Quarterly report: Q2 2025


Lexicon Pharmaceuticals Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Lexicon Pharmaceuticals Earnings release: Q2 2025


Lexicon Pharmaceuticals Slides: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Lexicon Pharmaceuticals Slides: Q2 2025


sabill
sabill Sep. 2 at 8:40 PM
$LXRX The occasional massive 4pm stock dumps sure screw up the average volume numbers.
0 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
0 · Reply
gucag006
gucag006 Sep. 2 at 6:30 PM
$LXRX Add some more this morning @2.21.
0 · Reply
CatchTheCleanUpSet
CatchTheCleanUpSet Sep. 2 at 5:56 PM
$LXRX Steno1 DKA results are now in hand.
1 · Reply
Hit1000X
Hit1000X Sep. 2 at 5:03 PM
0 · Reply
Dooright
Dooright Sep. 2 at 3:04 PM
$LXRX Fecking gap up this morning finally filled! 😖🙄 Doc C. 🤓
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:37 PM
$LXRX Tutes and MM's keep fucking with Debbane's 10 mil purchase in February. They keep poking the tiger. Just waiting with popcorn.
1 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:35 PM
$LXRX 3 dollar supports in short order.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 2 at 2:17 PM
$LXRX Oh look, it's climbing, what a surprise.
0 · Reply
Planetpaprika
Planetpaprika Sep. 2 at 11:41 AM
$LXRX Citi 2026 Biopharma Back to School Conference September 9, 2026, 11:20–11:55 AM (Eastern Time) 2026 Cantor Global Healthcare Conference September 10, 2026, 3:20–3:50 PM (Eastern Time) H.C. Wainwright 28th Annual Global Investment Conference September 14, 2026, 9:00–9:30 AM (Eastern Time)
0 · Reply
Psychicviking
Psychicviking Sep. 1 at 10:01 PM
$LXRX Green Wednesday!
0 · Reply
Kocatka
Kocatka Sep. 1 at 8:08 PM
$LXRX 9th -10th-14th Trifecta
1 · Reply
Hit1000X
Hit1000X Sep. 1 at 8:00 PM
$LXRX dca
1 · Reply
Islandman40
Islandman40 Sep. 1 at 6:01 PM
$LXRX STENO timeline is complete that should meet FDA requirements. Any day now for the announcement of the filing. I have waited 12 years for this moment. It is near I can feel it. 🙏🏽. I will wait twelve more if I have to. I believe in this company. 😀
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 5:50 PM
$LXRX Iran and Oil and Inflation don't mean shit here. Don't let them fool you. This is a hedge and alpha.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 5:47 PM
$LXRX MM's and Tutes are starting to push Debbane's buttons. And Exton. Lets see what happens.
0 · Reply
Rafrica
Rafrica Sep. 1 at 5:44 PM
$LXRX Why Lexicon Pharmaceuticals (LXRX) Is Back In The Spotlight - Simply Wall St News https://share.google/RbrXeP8MLHFobauni
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 5:15 PM
$LXRX expected date range of submittal=now. Obviously the Oral Pill does not eliminate the Insulin Jab completely. But it *greatly* lowers the occurence of needing to use it for glycemic, sugar control. As the Images coupled with the post indicate. Also of note: There is a $NVO 1 Bil deal $LXRX lx9851, different pathway to weightloss that preserves muscle mass, & eliminates flat face, & other negative effects of artificial GLP1 injected, vs lx9851 that helps the body CREATE it's OWN* natural GLP1 per body usage. Also $LXRX has cardio treatment indications. FDA approved, with new indication approval for HCM in phase 3 topline due early 2027. $LXRX also has in their pipeline, in Phase2b = there *NON OPIOID* Neuropathic Pain Treatment ( the worst pain you could possibly have )=Pilavapadin, has already successfully completed its Phase 2b clinical program (including the PROGRESS trial) &an End-of-Phase 2 meeting with the FDA,& it is currently advancing into Phase 3 development. $SPY
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 5:00 PM
$LXRX Submittal is pending and within expected date range of submittal. Obviously the Oral Pill does not eliminate the Insulin Jab completely. But it **greatly** lowers the occurence of needing to use it for glycemic, sugar control. As the Images coupled with the post indicate. Also of note: There is a $NVO 1 Bil agreement to use $LXRX lx9851 different pathway to weightloss that preserves muscle mass, and eliminates flat face, and other negative effects of artificial GLP1 injected, vs lx9851 that helps the body CREATE it's OWN** natural GLP1 per body usage. Also $LXRX has cardio treatment indications. FDA approved, with new indication approval for HCM in phase 3 topline due early 2027. $SPY $BIB $VTRS
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 4:47 PM
$LXRX Obviously the $LXRX Oral Pill does not eliminate the Insulin Jab completely. But it **greatly** lowers the occurence of needing to use it for glycemic, sugar control. As the Images coupled with the post indicate. $SPY $NVO $BIB $VTRS
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 4:11 PM
$LXRX = No More Painful Jabs for Insulin to glycemic ( Blood Sugar ) Control . THE FIRST ORAL PILL that helps in Type1 Diabetes, glycemic control. No more worrying about getting your glycemic count, 'just right' before or after a meal, fiddling with stress, needles, and back of the napkin calculations. First principles: Value ≈ P(approval) × payoff, and P just rose. STENO1 hit the FDA exposure bar in late August, showing DKA rates matching standard of care and well below inTandem—clearing the historical ~3.5 DKA/100 patient-years gating variable. Q4 NDA resubmission brings the first oral insulin adjunct for T1D glycemic control to ~1M US adults. Bayes prior: Administrations deliver high-salience, kitchen-table health wins into midterms (like the IRA $35 insulin cap in Aug '22). Amid soft jobs and sticky inflation, a non-injectable T1D option is prime political currency. $NVO $BIB $VTRS $SPY https://youtu.be/NPGAZFACUoc?si=N7pwImDrGAxveMWM
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Sep. 1 at 3:47 PM
0 · Reply